Close menu




October 5th, 2021 | 11:40 CEST

BioNTech, Varta, Sierra Grande Minerals - Is the countermovement coming?

  • Commodities
Photo credits: pixabay.com

The BioNTech share was under intense pressure in the past trading week. But even at the start of the week, the bulls could not prevail with a countermovement. There is also good news from the new German biotech star. Ripe for a rebound are also the shares of Varta and Sierra Grande. At Varta, the presentation of Apple's new Airpods could herald a share price recovery. Sierra Grande is suffering from weak precious metal prices. The Company has just published positive drilling results. Investors could soon look forward to rising prices for all three shares.

time to read: 3 minutes | Author: Fabian Lorenz
ISIN: BIONTECH SE SPON. ADRS 1 | US09075V1026 , VARTA AG O.N. | DE000A0TGJ55 , Sierra Grande Minerals | CA82631L1085

Table of contents:


    Sierra Grande: Out of the sideways trend with good drilling results?

    Sierra Grande Minerals seems to be ripe for a countermovement. The Canadian exploration company has focused on the development of gold, silver, copper and molybdenum projects. The projects are located in the USA in the state of Nevada. Just recently, the first soil sample results from the Betty East project were reported. It is located less than 20 kilometers south of Kinross Gold's Tier 1 Round Mountain mine, and the results were positive. That suggests two promising trends. The northern trend "Knolls" shows distinct deposits of gold and arsenic, and the soil samples have extended the previous trend. A new trend has even been encountered to the northeast of the project. This trend shows silver, arsenic, antimony, mercury and molybdenum and is over 1.5 km long and up to 1.0 km wide.

    Sonny Janda, President and Chief Executive Officer of Sierra, commented, "The results of our soil geochemical survey program at Betty East are very encouraging and confirm the existence of gold-bearing structures. Most intriguing, however, is the broad, apparently east and northeast trending soil geochemical anomaly containing multiple elements. We look forward to further exploring and evaluating this area in the coming months." In the coming months, Sierra Grande Minerals will focus on the new discovery to the northeast to evaluate the full extent better. An airborne magnetometer survey on the property is also being considered. Further details of the analysis should drive the share price, and perhaps sooner or later, big neighbor Kinross will grab it too.

    BioNTech: Countermovement after the crash?

    BioNTech shareholders needed strong nerves last week. The share fell to EUR 200. In August, it briefly traded above EUR 400. The reason for the recent price slide was the news that a Merck subsidiary will apply for emergency approval for a COVID-19 drug. It was foreseeable that sooner or later, an effective drug would come onto the market. But it will not replace vaccines. BioNTech should still be earning very well in 2022. At the same time, the biotech company is making progress in developing its cancer immunotherapies. The BNT122 vaccine for colorectal cancer, also based on mRNA technology, is now in phase 2 clinical trials, with around 200 patients in the US, Germany, Spain and Belgium expected to take part. It is already the second product from the cancer pipeline. Its efficacy against black skin cancer is also currently being investigated in a phase 2 trial. On Monday, the share at least caught itself and trended slightly positive. The price of EUR 400 was certainly exaggerated, but the share seems just as attractive at EUR 200.

    Varta: Tailwind from new Apple Airpods?

    In mid-August, Varta had published half-year figures. Since then, the battery specialist's stock has been on a downward trend, giving back virtually all of the year's gains. Investors were disappointed by the Company's outlook. Varta itself will not publish figures again until November 11, when it may raise its full-year forecast. Until then, Varta shares may get a tailwind from Apple. The tech company is a major customer of Varta. That is because Varta's microbatteries are in the Californians' Airpods. Now speculation is growing that Apple will introduce the third generation of its cordless headphones before the end of October. The last update was in April 2019, so the time seems ripe for a new generation. Especially since the Christmas shopping season is just around the corner. If Varta batteries are back on board, this should boost Varta shares and put the focus back on the Company's strong core business. However, analysts are traditionally cautious on Varta. Berenberg recently left its rating at "Hold" with a price target of EUR 125.


    The stock market is currently very volatile. However, there are indications of a countermovement in all three shares. BioNTech continues to earn well and is making progress with its vaccine pipeline. Sierra Grande Minerals has discovered previously unknown deposits, and Varta should benefit from Apple's new Airpods.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may in the future hold shares or other financial instruments of the mentioned companies or will bet on rising or falling on rising or falling prices and therefore a conflict of interest may arise in the future. conflict of interest may arise in the future. The Relevant Persons reserve the shares or other financial instruments of the company at any time (hereinafter referred to as the company at any time (hereinafter referred to as a "Transaction"). "Transaction"). Transactions may under certain circumstances influence the respective price of the shares or other financial instruments of the of the Company.

    Furthermore, Apaton Finance GmbH reserves the right to enter into future relationships with the company or with third parties in relation to reports on the company. with regard to reports on the company, which are published within the scope of the Apaton Finance GmbH as well as in the social media, on partner sites or in e-mails, on partner sites or in e-mails. The above references to existing conflicts of interest apply apply to all types and forms of publication used by Apaton Finance GmbH uses for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and etc. on news.financial. These contents serve information for readers and does not constitute a call to action or recommendations, neither explicitly nor implicitly. implicitly, they are to be understood as an assurance of possible price be understood. The contents do not replace individual professional investment advice and do not constitute an offer to sell the share(s) offer to sell the share(s) or other financial instrument(s) in question, nor is it an nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but rather financial analysis, but rather journalistic or advertising texts. Readers or users who make investment decisions or carry out transactions on the basis decisions or transactions on the basis of the information provided here act completely at their own risk. There is no contractual relationship between between Apaton Finance GmbH and its readers or the users of its offers. users of its offers, as our information only refers to the company and not to the company, but not to the investment decision of the reader or user. or user.

    The acquisition of financial instruments entails high risks that can lead to the total loss of the capital invested. The information published by Apaton Finance GmbH and its authors are based on careful research on careful research, nevertheless no liability for financial losses financial losses or a content guarantee for topicality, correctness, adequacy and completeness of the contents offered here. contents offered here. Please also note our Terms of use.


    Der Autor

    Fabian Lorenz

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author



    Related comments:

    Commented by Carsten Mainitz on November 11th, 2026 | 05:33 CET

    Boom with a Few Hurdles? Almonty, Rheinmetall and Renk Put to the Test! Is Now the Time to Buy?

    • Tungsten
    • Tungsten producer
    • Commodities
    • Critical raw materials
    • Military
    • Defence industry
    • Geopolitics
    • Investments

    Commodities, defence, returns. This formula for success has developed cracks. Following the recent sharp share price pullbacks, the crucial question is whether these are now buying opportunities or warning signals? With tungsten, Almonty is focusing on a strategic raw material with growing demand and considerable geopolitical significance. With the ramp-up of the South Korean Sangdong mine, Almonty is on the verge of a strong growth spurt. High prices, long-term offtake agreements and a further expansion phase also strengthen the sales outlook. Business at specialist Renk is running at full tilt. Following another forecast cut, Rheinmetall must offer investors a more reliable outlook. Where are the most attractive opportunities now?

    Read

    Commented by Stefan Feulner on November 11th, 2026 | 05:24 CET

    Energy Fuels, Standard Uranium and Denison Mines: Uranium market facing the next supply shock

    • Energy
    • Commodities

    The expansion of nuclear energy and the rising electricity demand from AI data centres are increasing the pressure on global uranium supplies. New reactors need fuel supplies secured for the long term, while developing additional deposits takes years. New production capacity is therefore being created in North America, existing facilities are being expanded, and previously undeveloped uranium regions are being explored more intensively. Canada and the USA are particularly in focus. This is where it will be decided which companies will be able to supply additional volumes in future.

    Read

    Commented by André Will-Laudien on November 6th, 2026 | 05:32 CET

    Midterm tsunami and new DAX record! Rheinmetall, Renk, SpaceX and Antimony Resources in the spotlight

    • Defence
    • IT technology
    • Artificial intelligence
    • Chip industry
    • Commodities
    • Critical metals

    Created and Published on Behalf of Antimony Resources Corp.

    The political earthquake in the US midterm elections is completely reshuffling the deck in the sensitive financial market and demands nerves of steel. With their triumphant sweep, the Democrats will now control both the House of Representatives and the Senate. This landslide victory, already described by many media outlets as a "blue tsunami", deprives President Donald Trump's Republicans of their parliamentary base. Substantial vote gains in traditionally conservative strongholds such as Texas and South Carolina were decisive to this success. American voters evidently used the midterm elections to express their discontent with the high cost of living and the economic consequences of recent foreign policy. For stock markets, this election result means a period of heightened volatility and political uncertainty. On Wall Street, investors must now prepare for the Democratic majority to scrutinise and block Trump's political plans. The newly elected Democratic representatives have already announced that they will focus on easing the burden on the population and strengthening regulation of large corporations. This shifts attention away from high oil prices, wars and protectionism toward digital renewal and the stabilisation of key supply chains. We look at a few outliers from the past few hours as Germany's benchmark DAX index climbs to new record highs.

    Read